[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 23 of about 23
1. Oosting-Lenstra SF, van Marwijk Kooy M: Failure of CHOP with rituximab for lymphomatoid granulomatosis. Neth J Med; 2007 Dec;65(11):442-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Failure of CHOP with rituximab for lymphomatoid granulomatosis.
  • We present a 66-year-old male patient with pulmonary lymphomatoid granulomatosis.
  • The patient had progressive disease after three courses of CHoP and rituximab and, therefore, treatment with interferon-alpha 2b 5 x 10(6) IE three times a week was started.
  • This resulted in stable disease for five months. subsequently, progression occurred and the patient died 12 months after initial presentation. lymphomatoid granulomatosis is a rare, poor-risk, Epstein-Barr virus related, B cell lymphoproliferative disease.
  • There is no standard treatment but promising results have been reported with rituximab, either as monotherapy or in combination with chemotherapy.
  • This case demonstrates that lymphomatoid granulomatosis is still a chemotherapy-resistant disease in some patients despite addition of rituximab.
  • A review of the literature regarding aetiology, clinical features, diagnosis and treatment options is presented.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Lymphomatoid Granulomatosis / drug therapy. Treatment Failure
  • [MeSH-minor] Aged. Antibodies, Monoclonal / administration & dosage. Antibodies, Monoclonal / therapeutic use. Antibodies, Monoclonal, Murine-Derived. Cyclophosphamide / administration & dosage. Disease Progression. Doxorubicin / administration & dosage. Fatal Outcome. Humans. Male. Prednisone / administration & dosage. Rituximab. Vincristine / administration & dosage

  • Genetic Alliance. consumer health - Lymphomatoid granulomatosis.
  • Hazardous Substances Data Bank. RITUXIMAB .
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18079567.001).
  • [ISSN] 0300-2977
  • [Journal-full-title] The Netherlands journal of medicine
  • [ISO-abbreviation] Neth J Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 4F4X42SYQ6 / Rituximab; 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
  •  go-up   go-down


2. Makol A, Kosuri K, Tamkus D, de M Calaca W, Chang HT: Lymphomatoid granulomatosis masquerading as interstitial pneumonia in a 66-year-old man: a case report and review of literature. J Hematol Oncol; 2009;2:39
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lymphomatoid granulomatosis masquerading as interstitial pneumonia in a 66-year-old man: a case report and review of literature.
  • Lymphomatoid granulomatosis (LG) is a rare, Epstein-Barr virus (EBV)-associated systemic angiodestructive lymphoproliferative disorder that may progress to a diffuse large B cell lymphoma.
  • Pulmonary involvement may mimic other more common lung pathologies including pneumonias.
  • Therapeutic standards have not been established for LG, but rituximab, interferon-alpha2b (INF-alpha2b), and chemotherapy have shown to improve symptoms and long term prognosis.We report a case of rapid respiratory deterioration in a 66-year-old man with clinical presentation, chest radiography, pulmonary function testing and high resolution computed tomography (HRCT) findings consistent with idiopathic interstitial pneumonia, but very poor response to antibiotics and low dose steroids.
  • The patient was treated with rituximab and combination chemotherapy and showed significant initial clinical improvement with gradual resolution of abnormal findings on imaging.
  • However, the patient developed pancytopenia as a complication of chemotherapy and died secondary to septic shock and renal failure that were refractory to medical management.
  • Autopsy showed diffuse alveolar damage but no evidence of any residual LG within the lungs.This case demonstrates that an open lung biopsy or video-assisted thoracoscopic surgical (VATS) biopsy is often necessary to rule out the presence of LG in order to determine the appropriate therapeutic strategy early in the course of illness to improve prognosis.
  • [MeSH-major] Lung Diseases, Interstitial / diagnosis. Lung Neoplasms / diagnosis. Lymphomatoid Granulomatosis / diagnosis


3. Cadranel J, Wislez M, Antoine M: Primary pulmonary lymphoma. Eur Respir J; 2002 Sep;20(3):750-62
The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for primary pulmonary lymphoma .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary pulmonary lymphoma.
  • Three distinct entities are now covered by the definition of primary pulmonary clonal lymphoid proliferation.
  • The aim of this review is to describe the pathophysiological, diagnostic, prognostic and therapeutic aspects of these three entities.
  • Low-grade pulmonary B-cell lymphoma is the most frequent form of primary pulmonary clonal lymphoid proliferation.
  • It arises from mucosa-associated lymphoid tissue.
  • The prognosis is excellent, but treatment is controversial (simple monitoring, surgery or single-agent chemotherapy).
  • High-grade pulmonary B-cell lymphoma is far rarer and usually occurs in individuals with an underlying disorder (e.g. immunodeficiency).
  • The prognosis is poor and therapeutic options depend on the underlying disorder.
  • The inclusion of lymphomatoid granulomatosis in the definition of primary pulmonary lymphomas is controversial.
  • The prognosis is extremely variable, with some authors reporting complete remission with steroids and cyclophosphamide and others reporting failure of combination chemotherapy.
  • [MeSH-major] Lung Neoplasms. Lymphoma, B-Cell. Lymphomatoid Granulomatosis
  • [MeSH-minor] Humans. Lymphoma, B-Cell, Marginal Zone / diagnosis. Lymphoma, B-Cell, Marginal Zone / pathology. Lymphoma, B-Cell, Marginal Zone / therapy. Lymphoma, Non-Hodgkin / diagnosis. Lymphoma, Non-Hodgkin / pathology. Lymphoma, Non-Hodgkin / therapy

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12358356.001).
  • [ISSN] 0903-1936
  • [Journal-full-title] The European respiratory journal
  • [ISO-abbreviation] Eur. Respir. J.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Denmark
  • [Number-of-references] 108
  •  go-up   go-down


Advertisement
4. Moudir-Thomas C, Foulet-Roge A, Plat M, Kaswin R, Lepic P, Solal-Celigny P, Lebas FX: [Efficacy of rituximab in lymphomatoid granulomatosis]. Rev Mal Respir; 2004 Dec;21(6 Pt 1):1157-61
Hazardous Substances Data Bank. RITUXIMAB .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Efficacy of rituximab in lymphomatoid granulomatosis].
  • INTRODUCTION: Lymphomatoid Granulomatosis is a rare and serious disease, now considered to be a B-cell lymphoma, which is frequently associated with Epstein-Barr virus infection.
  • There is no consensus on treatment, which is usually based on steroid therapy, either alone or combined with cyclophosphamide and combination chemotherapy.
  • The diagnosis of Lymphomatoid Granulomatosis was made on the basis of surgical lung biopsy.
  • Treatment with anti CD 20 monoclonal antibodies (rituximab) led initially to a reduction in parenchymal abnormalities and mediastinal adenopathy.
  • CONCLUSION: This treatment, recently used in Lymphomatoid Granulomatosis with pulmonary involvement, has shown promising results.
  • Rituximab can be used in combination chemotherapy as standard treatment for aggressive B-cell lymphoma.
  • [MeSH-major] Antibodies, Monoclonal / therapeutic use. Antineoplastic Agents / therapeutic use. Lung Diseases / drug therapy. Lymphomatoid Granulomatosis / drug therapy

  • Genetic Alliance. consumer health - Lymphomatoid granulomatosis.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Lung Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15767962.001).
  • [ISSN] 0761-8425
  • [Journal-full-title] Revue des maladies respiratoires
  • [ISO-abbreviation] Rev Mal Respir
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 0 / Antineoplastic Agents; 4F4X42SYQ6 / Rituximab
  •  go-up   go-down


5. Váróczy L, Gergely L, Szakáll S, Illés A: Angiocentric lymphomatoid granulomatosis and severe hypogammaglobulinaemia. Haematologia (Budap); 2002;32(4):535-41
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Angiocentric lymphomatoid granulomatosis and severe hypogammaglobulinaemia.
  • Angiocentric lymphomatoid granulomatosis is a rare lymphoproliferative disease, mainly associated with pulmonary manifestation.
  • No specific therapy was administered.
  • In February 1998 multiple pulmonary lesions were found by X-ray and thoracoscopic biopsy was made.
  • The histopathological diagnosis was angiocentric lymphomatoid granulomatosis.
  • The patient received 6 cycles of CHOP chemotherapy, with which a complete remission was achieved.
  • The diagnosed CVID was the probable causative factor of the angiocentric lymphomatoid granulomatosis.
  • After the CHOP treatment, the patient is on intravenous immunoglobulin substitution and is well up to today.
  • [MeSH-major] Agammaglobulinemia / complications. Lymphomatoid Granulomatosis / complications
  • [MeSH-minor] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Common Variable Immunodeficiency / complications. Common Variable Immunodeficiency / therapy. Cyclophosphamide / therapeutic use. Doxorubicin / therapeutic use. Humans. Immunoglobulins, Intravenous / therapeutic use. Male. Middle Aged. Prednisone / therapeutic use. Vincristine / therapeutic use

  • Genetic Alliance. consumer health - Lymphomatoid granulomatosis.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12803130.001).
  • [ISSN] 0017-6559
  • [Journal-full-title] Haematologia
  • [ISO-abbreviation] Haematologia (Budap)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Immunoglobulins, Intravenous; 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
  •  go-up   go-down


6. Robak T, Kordek R, Urbanska-Rys H, Robak P, Bartkowiak J, Bednarek A, Chudobinski C, Chojnowski K: High activity of rituximab combined with cladribine and cyclophosphamide in a patient with pulmonary lymphomatoid granulomatosis and bone marrow involvement. Leuk Lymphoma; 2006 Aug;47(8):1667-9
Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High activity of rituximab combined with cladribine and cyclophosphamide in a patient with pulmonary lymphomatoid granulomatosis and bone marrow involvement.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Lymphomatoid Granulomatosis / drug therapy
  • [MeSH-minor] Antibodies, Monoclonal / therapeutic use. Antibodies, Monoclonal, Murine-Derived. Bone Marrow Diseases. Cladribine / therapeutic use. Cyclophosphamide / therapeutic use. Female. Humans. Lung Diseases. Middle Aged. Rituximab

  • Genetic Alliance. consumer health - Lymphomatoid granulomatosis.
  • Hazardous Substances Data Bank. RITUXIMAB .
  • Hazardous Substances Data Bank. CLADRIBINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16966281.001).
  • [ISSN] 1042-8194
  • [Journal-full-title] Leukemia & lymphoma
  • [ISO-abbreviation] Leuk. Lymphoma
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 47M74X9YT5 / Cladribine; 4F4X42SYQ6 / Rituximab; 8N3DW7272P / Cyclophosphamide
  •  go-up   go-down


7. Jung KH, Sung HJ, Lee JH, Lee KY, Shin JS, Kim KM, Kim YS, Shin C, Kim JH: A case of pulmonary lymphomatoid granulomatosis successfully treated by combination chemotherapy with rituximab. Chemotherapy; 2009;55(5):386-90
Hazardous Substances Data Bank. VINCRISTINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of pulmonary lymphomatoid granulomatosis successfully treated by combination chemotherapy with rituximab.
  • Lymphomatoid granulomatosis (LYG) is a rare angiocentric and angiodestructive lymphoproliferative disease characterized by Epstein-Barr virus-positive B cells admixed with reactive T cells.
  • Pulmonary LYG usually presents as multiple pulmonary nodules with rapid progression and excavation.
  • Standard treatment for LYG has not yet been established.
  • Despite combination chemotherapy, the overall prognosis is poor.
  • We report the case of a 70-year-old male patient with pulmonary LYG, who showed rapid remission of the disease after combination chemotherapy with rituximab.
  • [MeSH-major] Antibodies, Monoclonal / administration & dosage. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Lung Neoplasms / drug therapy. Lymphomatoid Granulomatosis / drug therapy
  • [MeSH-minor] Aged. Antibodies, Monoclonal, Murine-Derived. Cyclophosphamide / administration & dosage. Cyclophosphamide / therapeutic use. Humans. Male. Prednisolone / administration & dosage. Prednisolone / therapeutic use. Rituximab. Vincristine / administration & dosage. Vincristine / therapeutic use

  • Genetic Alliance. consumer health - Lymphomatoid granulomatosis.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • Hazardous Substances Data Bank. RITUXIMAB .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. PREDNISOLONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 S. Karger AG, Basel.
  • (PMID = 19752554.001).
  • [ISSN] 1421-9794
  • [Journal-full-title] Chemotherapy
  • [ISO-abbreviation] Chemotherapy
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 4F4X42SYQ6 / Rituximab; 5J49Q6B70F / Vincristine; 8N3DW7272P / Cyclophosphamide; 9PHQ9Y1OLM / Prednisolone
  •  go-up   go-down


8. Friedrichs B, Thiel E: [Relapsed pulmonary lymphomatoid granulomatosis grade III: curative treatment with radioimmune therapy and autologous stem cell transplantation]. Dtsch Med Wochenschr; 2010 Sep;135(38):1857-60
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Relapsed pulmonary lymphomatoid granulomatosis grade III: curative treatment with radioimmune therapy and autologous stem cell transplantation].
  • [Transliterated title] Pulmonale lymphomatoide Granulomatose Grad III: kurativer Therapieansatz mit Radioimmuntherapie und autologer Stammzelltransplantation.
  • INVESTIGATIONS: A chest X-ray and subsequent computed tomography (CT) scans showed a lesion measuring 10×8 cm in the right upper pulmonary lobe.
  • These findings were consistent with lymphomatoid granulomatosis grade III.
  • TREATMENT AND COURSE: After 6 cycles of rituximab, cyclophosphamide, doxorubicin, vincristin and prednisolone (R-CHOP), an early relapse developed which was treated with rituximab, ifosphamid, methotrexate and etoposide.
  • Good partial remission was achieved after consolidating high-dose chemotherapy followed by autologous stem cell transplantation (ASCT).
  • After two years of rituximab maintenance treatment positron emission tomography (PET-CT) revealed an increase of metabolic activity.
  • A second high-dose therapy was then combined with Y-90 ibritumomab tiuxetan, which was well tolerated.
  • Histology did not reveal any residual active lymphomatoid granulomatosis.
  • CONCLUSIONS: Combination of Y-90 ibritumomab tiuxetan and high-dose chemotherapy followed by ASCT may offer an efficacious and well-tolerated targeted treatment approach for patients with relapsed lymphomatoid granulomatosis.
  • [MeSH-major] Antibodies, Monoclonal / therapeutic use. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Hematopoietic Stem Cell Transplantation. Lung Neoplasms / therapy. Lymphomatoid Granulomatosis / therapy. Neoplasm Recurrence, Local / therapy
  • [MeSH-minor] Adult. Combined Modality Therapy. Dose-Response Relationship, Drug. Female. Humans. Image Processing, Computer-Assisted. Infant. Lung / pathology. Pneumonectomy. Positron-Emission Tomography. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Lymphomatoid granulomatosis.
  • Genetic Alliance. consumer health - Transplantation.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © Georg Thieme Verlag KG Stuttgart · New York.
  • (PMID = 20842604.001).
  • [ISSN] 1439-4413
  • [Journal-full-title] Deutsche medizinische Wochenschrift (1946)
  • [ISO-abbreviation] Dtsch. Med. Wochenschr.
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / ibritumomab tiuxetan
  •  go-up   go-down


9. Melegh Z, Sutak J, Whiteway A, Rooney N, Pawade J: Lymphomatoid granulomatosis of the uterine cervix. Pathol Res Pract; 2009;205(5):371-4
International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lymphomatoid granulomatosis of the uterine cervix.
  • Lymphomatoid granulomatosis is an Epstein-Barr virus-driven lymphoproliferative disorder, usually with a prominent pulmonary involvement and occasional extrapulmonary manifestations.
  • Here, we present a case of lymphomatoid granulomatosis confined to the uterine cervix at the initial diagnosis.
  • The disease was preceded by an immunosuppressive condition, namely low-grade lymphoplasmacytic lymphoma treated with chemotherapy.
  • This is the first report of lymphomatoid granulomatosis at this site and emphasizes that it can present at unusual sites, such as the female genital tract in immunosuppressed patients.
  • [MeSH-major] Immunocompromised Host. Lymphomatoid Granulomatosis / immunology. Neoplasms, Second Primary / immunology. Uterine Cervical Neoplasms / immunology
  • [MeSH-minor] Aged. Antineoplastic Agents / therapeutic use. Epstein-Barr Virus Infections / complications. Female. Humans. Immunohistochemistry. In Situ Hybridization. Palatine Tonsil / metabolism. Palatine Tonsil / pathology. RNA, Viral / analysis. Waldenstrom Macroglobulinemia / drug therapy. Waldenstrom Macroglobulinemia / pathology

  • Genetic Alliance. consumer health - Lymphomatoid granulomatosis.
  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19147299.001).
  • [ISSN] 1618-0631
  • [Journal-full-title] Pathology, research and practice
  • [ISO-abbreviation] Pathol. Res. Pract.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Epstein-Barr virus encoded RNA 2; 0 / RNA, Viral
  •  go-up   go-down


10. Moertel CL, Carlson-Green B, Watterson J, Simonton SC: Lymphomatoid granulomatosis after childhood acute lymphoblastic leukemia: report of effective therapy. Pediatrics; 2001 May;107(5):E82
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lymphomatoid granulomatosis after childhood acute lymphoblastic leukemia: report of effective therapy.
  • Lymphomatoid granulomatosis, a rare condition in children, affects the lungs primarily but may have significant extrapulmonary manifestations, especially in the central nervous system.
  • We report a case of lymphomatoid granulomatosis with onset after the completion of chemotherapy for childhood acute lymphoblastic leukemia.
  • Two months after treatment ended, the 7-year-old girl developed splenomegaly, cervical adenopathy, and bilateral interstitial pulmonary infiltrates.
  • A computed tomography scan of the head was normal, but her pulmonary infiltrates had become nodular.
  • A computed tomography-guided biopsy of 1 of the nodules revealed cellular interstitial pneumonitis.
  • One month later, she had persistent pulmonary infiltrates, marked splenomegaly, and new seizures.
  • Itraconazole was begun, and the pulmonary infiltrates resolved.
  • Five months after her initial symptoms, she developed tonic pupil and a decreased level of consciousness.
  • Open-lung biopsy revealed lymphomatoid granulomatosis.
  • Lymphoma-directed therapy was initiated, and the patient had complete resolution of pulmonary and cerebral nodules 5 months later.
  • No intrathecal chemotherapy was administered, and radiation therapy was not necessary.
  • Neuropsychological testing obtained after completion of therapy revealed an improvement in attention, coordination, and fine motor speed over time.
  • [MeSH-major] Brain Neoplasms / diagnosis. Lung Neoplasms / diagnosis. Lymphomatoid Granulomatosis / diagnosis. Neoplasms, Second Primary / diagnosis. Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • [MeSH-minor] Antineoplastic Agents / therapeutic use. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Biopsy. Child, Preschool. Female. Humans. Magnetic Resonance Imaging


11. Güven A, Baskin D: Lymphomatoid granulomatosis in a boy with long-term follow-up. Pediatr Hematol Oncol; 2001 Sep;18(6):377-82
Genetic Alliance. consumer health - Lymphomatoid granulomatosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lymphomatoid granulomatosis in a boy with long-term follow-up.
  • Lymphomatoid granulomatosis is an angiocentric lymphoreticular proliferative disease.
  • The authors describe a patient who presented at the age of 12 years with pulmonary nodules and hepatosplenomegaly and was followed up for 6 years, and who subsequently developed lymphoma after cessation of therapy.
  • [MeSH-major] Lymphomatoid Granulomatosis / diagnosis
  • [MeSH-minor] Child. Hodgkin Disease. Humans. Lung Neoplasms / diagnosis. Lung Neoplasms / drug therapy. Male. Neoplasms, Second Primary. Skin Neoplasms / diagnosis. Skin Neoplasms / drug therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11554232.001).
  • [ISSN] 0888-0018
  • [Journal-full-title] Pediatric hematology and oncology
  • [ISO-abbreviation] Pediatr Hematol Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


12. Cachat F, Meagher-Villemure K, Guignard JP: Lymphomatoid granulomatosis in a renal transplant patient. Pediatr Nephrol; 2003 Aug;18(8):838-42
MedlinePlus Health Information. consumer health - Kidney Transplantation.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lymphomatoid granulomatosis in a renal transplant patient.
  • Lymphomatoid granulomatosis is a rare angiocentric and angiodestructive pulmonary angiitis considered as a variant of the lymphoproliferative disorder group.
  • However, lymphomatoid granulomatosis has rarely been described in patients with renal transplantation.
  • It often presents with severe pulmonary signs.
  • We review the radiological and pathological findings and discuss the etiopathogenesis and therapeutic options of this particular lymphoproliferative disorder.
  • With careful and stepwise reduction in her immunosuppression, our patient showed a complete disappearance of her lymphomatoid granulomatosis, and she is clinically well more than 3 years after the diagnosis, with good kidney function.
  • [MeSH-major] Immunosuppressive Agents / adverse effects. Kidney Transplantation. Lymphomatoid Granulomatosis / chemically induced
  • [MeSH-minor] Adolescent. Female. Graft Rejection / drug therapy. Humans. Magnetic Resonance Imaging. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Lymphomatoid granulomatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Pathol. 1972 Dec;3(4):457-558 [4638966.001]
  • [Cites] Dtsch Med Wochenschr. 1997 Sep 12;122(37):1106-10 [9340250.001]
  • [Cites] Blood. 1996 Jun 1;87(11):4531-7 [8639820.001]
  • [Cites] Acta Radiol. 1996 Jul;37(4):496-505 [8688230.001]
  • [Cites] Surg Neurol. 1999 Mar;51(3):258-60 [10086488.001]
  • [Cites] J Neurosurg. 1987 Oct;67(4):612-5 [3655900.001]
  • [Cites] J Neuroimaging. 1997 Apr;7(2):120-1 [9128453.001]
  • [Cites] Br J Rheumatol. 1989 Feb;28(1):77-8 [2917235.001]
  • [Cites] Am J Hematol. 1999 Dec;62(4):239-41 [10589080.001]
  • [Cites] J Child Neurol. 1992 Jul;7(3):295-9 [1634753.001]
  • [Cites] Mayo Clin Proc. 1990 Feb;65(2):151-63 [2304362.001]
  • [Cites] Bone Marrow Transplant. 1999 Jan;23(1):79-81 [10037054.001]
  • [Cites] Arch Neurol. 1994 Jul;51(7):671-5 [8018039.001]
  • [Cites] Ann Intern Med. 1987 Dec;107(6):945 [3688694.001]
  • [Cites] Radiology. 1998 Sep;208(3):663-9 [9722843.001]
  • [Cites] J Pediatr Surg. 1999 Jun;34(6):1033-5 [10392931.001]
  • [Cites] J Neurol. 1997 Oct;244(10):639-45 [9402541.001]
  • [Cites] J Otolaryngol. 1979 Dec;8(6):549-55 [393839.001]
  • [Cites] Hum Pathol. 1988 Sep;19(9):1109-12 [3417293.001]
  • [Cites] J Neurosurg. 1994 Feb;80(2):314-20 [8283271.001]
  • [Cites] Mod Pathol. 1998 Apr;11(4):347-56 [9578085.001]
  • [Cites] Transplantation. 1988 Apr;45(4):719-27 [2833828.001]
  • [Cites] Pediatr Nephrol. 1999 Nov;13(9):748-54 [10603113.001]
  • [Cites] J Comput Assist Tomogr. 1990 Mar-Apr;14(2):291-3 [2312861.001]
  • [Cites] Cancer Surv. 1997;30:233-48 [9547995.001]
  • [Cites] Transplantation. 1995 Jan 27;59(2):240-4 [7839447.001]
  • [Cites] Hum Pathol. 1989 Apr;20(4):326-34 [2703227.001]
  • [Cites] AJNR Am J Neuroradiol. 1988 Nov-Dec;9(6):1139-43 [3143235.001]
  • [Cites] Cancer. 1990 Mar 15;65(6):1345-9 [2155052.001]
  • [Cites] Pathology. 1979 Jul;11(3):537-50 [523188.001]
  • [Cites] Ann Dermatol Venereol. 2000 May;127(5):488-91 [10863178.001]
  • [Cites] Ann Neurol. 1984 May;15(5):478-81 [6732195.001]
  • [Cites] N Engl J Med. 1982 Jan 14;306(2):68-74 [7053488.001]
  • [Cites] Transplantation. 1993 Jul;56(1):88-96 [8333073.001]
  • [Cites] Hum Pathol. 1976 Jan;7(1):111-6 [1104468.001]
  • [Cites] Acta Neuropathol. 1983;61(2):141-7 [6356768.001]
  • [Cites] Am J Dis Child. 1993 Jun;147(6):693-4 [8506845.001]
  • [Cites] J Neuroophthalmol. 1998 Jun;18(2):150-2 [9621274.001]
  • [Cites] Cancer. 1979 Jan;43(1):360-73 [761171.001]
  • [Cites] Chest. 1993 Feb;103(2):650-1 [8432184.001]
  • [Cites] AJR Am J Roentgenol. 1994 Aug;163(2):273-81 [8037014.001]
  • [Cites] Cancer. 1986 Aug 15;58(4):969-72 [3521844.001]
  • [Cites] Australas Radiol. 1997 Feb;41(1):57-62 [9125071.001]
  • [Cites] Aust N Z J Med. 1979 Aug;9(4):434-6 [389224.001]
  • (PMID = 12802639.001).
  • [ISSN] 0931-041X
  • [Journal-full-title] Pediatric nephrology (Berlin, Germany)
  • [ISO-abbreviation] Pediatr. Nephrol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Immunosuppressive Agents
  •  go-up   go-down


13. Ragage F, Parrens M, Banos A, Renoux M, Bégueret H, Merlio JP, de Mascarel A: [Lymphomatoid granulomatosis after treatment of an acute myeloid leukemia]. Ann Pathol; 2006 Feb;26(1):22-5
MedlinePlus Health Information. consumer health - Acute Myeloid Leukemia.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Lymphomatoid granulomatosis after treatment of an acute myeloid leukemia].
  • We report a case of lymphomatoid granulomatosis (LG), arising in a 60-year-old man in the setting of an acute myeloid leukemia.
  • Patients usually present with respiratory symptoms and bilateral pulmonary nodules.
  • The differential diagnosis mainly includes pulmonary vasculitis and Hodgkin's lymphoma.
  • [MeSH-major] Leukemia, Myeloid, Acute / drug therapy. Lymphomatoid Granulomatosis / pathology
  • [MeSH-minor] Antigens, CD / analysis. Biopsy. Diagnosis, Differential. Epstein-Barr Virus Infections / pathology. Epstein-Barr Virus Nuclear Antigens / analysis. Humans. Male. Middle Aged. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Leukemia, Myeloid.
  • Genetic Alliance. consumer health - Lymphomatoid granulomatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16841006.001).
  • [ISSN] 0242-6498
  • [Journal-full-title] Annales de pathologie
  • [ISO-abbreviation] Ann Pathol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Epstein-Barr Virus Nuclear Antigens
  •  go-up   go-down


14. Zaidi A, Kampalath B, Peltier WL, Vesole DH: Successful treatment of systemic and central nervous system lymphomatoid granulomatosis with rituximab. Leuk Lymphoma; 2004 Apr;45(4):777-80
Hazardous Substances Data Bank. RITUXIMAB .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Successful treatment of systemic and central nervous system lymphomatoid granulomatosis with rituximab.
  • Lymphomatoid granulomatosis (LYG) is a rare lymphoproliferative disorder with a mortality rate approaching 60% in the first year.
  • The median survival is 14 months from the time of diagnosis.
  • Although a variety of chemotherapeutic regimens have been utilized, there is no standard treatment.
  • We report a case of LYG with pulmonary, hepatic, central and peripheral nervous system involvement that was successfully treated with the anti-CD20 (B-cell) monoclonal antibody, Rituximab.
  • [MeSH-major] Antibodies, Monoclonal / therapeutic use. Central Nervous System Neoplasms / drug therapy. Lymphomatoid Granulomatosis / drug therapy
  • [MeSH-minor] Antibodies, Monoclonal, Murine-Derived. B-Lymphocytes. Disease-Free Survival. Humans. Immunohistochemistry. Male. Middle Aged. Neoplasm Invasiveness / pathology. Remission Induction. Rituximab. T-Lymphocytes. Treatment Outcome

  • Genetic Alliance. consumer health - Lymphomatoid granulomatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15160955.001).
  • [ISSN] 1042-8194
  • [Journal-full-title] Leukemia & lymphoma
  • [ISO-abbreviation] Leuk. Lymphoma
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 4F4X42SYQ6 / Rituximab
  •  go-up   go-down


15. Kameda H, Okuyama A, Tamaru J, Itoyama S, Iizuka A, Takeuchi T: Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis. Clin Rheumatol; 2007 Sep;26(9):1585-9
Hazardous Substances Data Bank. METHOTREXATE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis.
  • We report on a patient of rheumatoid arthritis (RA) who sequentially developed an axillary mass and a fatal interstitial pneumonia during a 2-year course of methotrexate (MTX) therapy.
  • Autopsy revealed a systemic lymph node involvement and the diagnosis of Epstein-Barr virus (EBV)-related lymphoproliferative disease (LPD) with the features of lymphomatoid granulomatosis was made.
  • The lung tissue specimens revealed a typical diffuse alveolar damage (DAD), and small nodules consisting of atypical B lymphocytes showing positive staining for EBV were sparsely recognized only in basal lungs.
  • This is the first report of a RA patient receiving MTX therapy sequentially developing MTX-associated lymphomatoid granulomatosis and DAD.
  • [MeSH-minor] Aged. Arthritis, Rheumatoid / drug therapy. Fatal Outcome. Humans. Lymphomatoid Granulomatosis / etiology. Male. Pneumonia / chemically induced. Pulmonary Alveoli / pathology. Pulmonary Alveoli / virology

  • Genetic Alliance. consumer health - Lymphomatoid granulomatosis.
  • Genetic Alliance. consumer health - Arthritis.
  • Genetic Alliance. consumer health - Rheumatoid arthritis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Med Invest. 1999 Aug;46(3-4):151-8 [10687309.001]
  • [Cites] J Rheumatol. 1987 Dec;14 (6):1164-71 [3325643.001]
  • [Cites] Semin Arthritis Rheum. 1997 Jun;26(6):794-804 [9213378.001]
  • [Cites] Chest. 2003 Jun;123(6):2150-3 [12796204.001]
  • [Cites] Arthritis Rheum. 1996 Feb;39(2):272-6 [8849378.001]
  • [Cites] J Natl Cancer Inst. 2004 Nov 17;96(22):1691-702 [15547182.001]
  • [Cites] J Rheumatol. 1997 Dec;24(12):2299-303 [9415631.001]
  • [Cites] Br J Haematol. 2002 Aug;118(2):567-8 [12139747.001]
  • [Cites] Clin Rheumatol. 1997 May;16(3):321-3 [9184276.001]
  • [Cites] Semin Arthritis Rheum. 1987 Feb;16(3):186-95 [3823910.001]
  • [Cites] Arthritis Rheum. 1997 Oct;40(10 ):1829-37 [9336418.001]
  • [Cites] Am J Med. 1995 Sep;99(3):276-81 [7653488.001]
  • [Cites] Rheumatology (Oxford). 2002 Dec;41(12 ):1346-56 [12468813.001]
  • [Cites] Blood. 2002 Jun 1;99(11):3909-15 [12010788.001]
  • [Cites] Arthritis Rheum. 2004 Jun;50(6):1740-51 [15188349.001]
  • [Cites] Eur Respir J. 2000 Feb;15(2):373-81 [10706507.001]
  • [Cites] Arthritis Rheum. 2000 Jan;43(1):14-21 [10643695.001]
  • [Cites] Rheum Dis Clin North Am. 1997 Nov;23(4):917-37 [9361161.001]
  • [Cites] J Rheumatol. 1994 Jan;21(1):51-4 [8151587.001]
  • (PMID = 17200802.001).
  • [ISSN] 0770-3198
  • [Journal-full-title] Clinical rheumatology
  • [ISO-abbreviation] Clin. Rheumatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Immunosuppressive Agents; YL5FZ2Y5U1 / Methotrexate
  •  go-up   go-down


16. Sladkopevtsev AS, Mikhailova LP, Makarova OV, Kovaleva VL, Veselova NI: Antiinflammatory effect of russian-made budesonide in experimental noninfectious pulmonary granulomatosis. Bull Exp Biol Med; 2001 May;131(5):473-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Antiinflammatory effect of russian-made budesonide in experimental noninfectious pulmonary granulomatosis.
  • We studied the antiinflammatory effect of a Russian-made glucocorticoid budesonide administered by inhalation and intraperitoneal injection to rats with experimental noninfectious pulmonary granulomatosis.
  • [MeSH-major] Anti-Inflammatory Agents / therapeutic use. Budesonide / therapeutic use. Lymphomatoid Granulomatosis / drug therapy
  • [MeSH-minor] Administration, Inhalation. Animals. Bronchoalveolar Lavage Fluid. Hyperplasia / drug therapy. Infusions, Parenteral. Lung / drug effects. Male. Rats. Rats, Wistar. Time Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11550057.001).
  • [ISSN] 0007-4888
  • [Journal-full-title] Bulletin of experimental biology and medicine
  • [ISO-abbreviation] Bull. Exp. Biol. Med.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents; 51333-22-3 / Budesonide
  •  go-up   go-down


17. Rakusić N, Krmpotić D, Hećimović A, Boras Z, Vrabec-Branica B, Dzebro S, Rakusić N, Resković T, Rakusić N: Lymphomatoid granulomatosis in a 23-year-old man--cytological and histological typing and rapid response to steroid and cyclophosphamide combination therapy. Coll Antropol; 2010 Mar;34(1):279-83
Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lymphomatoid granulomatosis in a 23-year-old man--cytological and histological typing and rapid response to steroid and cyclophosphamide combination therapy.
  • Lymphomatoid granulomatosis (LG) is currently called as extranodal angiocentric and angiodestructive immunoproliferative disorder with various degrees of histological differentiation and disease severity.
  • We report the case of a 23-year-old man clinically presented with fever, sweating, and physical intolerance, and bilateral pulmonary infiltrates of nodular type and destructive changes on the chest X-ray, previously treated with antituberculotics for 1.5 month.
  • LG was confirmed by open lung biopsy, followed by induction of corticosteroids and cyclophosphamide therapy.
  • [MeSH-major] Adrenal Cortex Hormones / administration & dosage. Cyclophosphamide / administration & dosage. Lung Neoplasms / drug therapy. Lung Neoplasms / pathology. Lymphomatoid Granulomatosis / drug therapy. Lymphomatoid Granulomatosis / pathology
  • [MeSH-minor] Antineoplastic Agents, Alkylating / administration & dosage. B-Lymphocytes / pathology. B-Lymphocytes / virology. Biopsy, Fine-Needle. Drug Therapy, Combination. Epstein-Barr Virus Infections / pathology. Humans. Lung / pathology. Male. Remission Induction. Young Adult

  • Genetic Alliance. consumer health - Lymphomatoid granulomatosis.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Steroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20437644.001).
  • [ISSN] 0350-6134
  • [Journal-full-title] Collegium antropologicum
  • [ISO-abbreviation] Coll Antropol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Croatia
  • [Chemical-registry-number] 0 / Adrenal Cortex Hormones; 0 / Antineoplastic Agents, Alkylating; 8N3DW7272P / Cyclophosphamide
  •  go-up   go-down


18. Erdur B, Yilmaz S, Oren H, Demircioğlu F, Cakmakç H, Irken G: Evaluating pulmonary complications in childhood acute leukemias. J Pediatr Hematol Oncol; 2008 Jul;30(7):522-6
MedlinePlus Health Information. consumer health - Pneumonia.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evaluating pulmonary complications in childhood acute leukemias.
  • SUMMARY: We evaluated the frequency, etiologic factors, outcome, and the comorbid conditions affecting the morbidity and mortality of pulmonary complications in acute childhood leukemia.
  • Sixty-six (40.4%) out of 163 patients developed 79 pulmonary complications.
  • Acute respiratory distress syndrome, leukostasis, lymphomatoid granulomatosis, pulmonary edema, and pneumothorax were among the noninfectious causes.
  • The pulmonary complications in the induction and consolidation phase of leukemia therapy were more severe and the mortality rate was higher.
  • Tachypnea, shock, oxygen and mechanical ventilation requirement, disseminated intravascular coagulation, involvement of other organs or systems, cytopenias, requirement of modification in antimicrobial drugs were found to be related with increased mortality risk.
  • The mortality rate of pulmonary complications was 8.9%.
  • Pulmonary infections in the maintenance phase of the therapy were frequently treated with oral antibiotics, and they were generally rapidly taken under control.
  • In conclusion, pulmonary complications are frequent in children with acute leukemia, and early diagnosis and appropriate management are important to avoid mortality owing to pulmonary complications, especially in neutropenic patients receiving induction or consolidation phase of chemotherapy.
  • [MeSH-minor] Acute Disease. Adolescent. Anti-Bacterial Agents / therapeutic use. Antineoplastic Agents / adverse effects. Child. Child, Preschool. Comorbidity. Disseminated Intravascular Coagulation / etiology. Disseminated Intravascular Coagulation / mortality. Female. Humans. Infant. Male. Multiple Organ Failure / etiology. Multiple Organ Failure / mortality. Neutropenia / chemically induced. Neutropenia / complications. Pneumothorax / complications. Pneumothorax / epidemiology. Pulmonary Edema / complications. Pulmonary Edema / epidemiology. Respiration, Artificial / utilization. Respiratory Distress Syndrome, Adult / complications. Respiratory Distress Syndrome, Adult / epidemiology. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Childhood Leukemia.
  • MedlinePlus Health Information. consumer health - Leukemia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18797199.001).
  • [ISSN] 1536-3678
  • [Journal-full-title] Journal of pediatric hematology/oncology
  • [ISO-abbreviation] J. Pediatr. Hematol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 0 / Antineoplastic Agents
  •  go-up   go-down


19. Marica C, Galbenu P, Galie N, Tănăsescu M: [Pulmonary benign lymphocytic angiitis and granulomatosis--a benign lymphoproliferative condition]. Pneumologia; 2002 Oct-Dec;51(4):302-5
Hazardous Substances Data Bank. PREDNISONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Pulmonary benign lymphocytic angiitis and granulomatosis--a benign lymphoproliferative condition].
  • BLAG--benign lymphocytic angiitis and granulomatosis is a granulomatosis disease which histologically presents a dense infiltrate of lympnoid cells that disturbes the normal alveolar architecture.
  • The treatment was a combination of cyclophosphamide and prednisone.
  • Follow up information after 9 month of treatment show a generally favorable evolution (clinical and radiological).
  • [MeSH-major] Lung Diseases / pathology. Lymphomatoid Granulomatosis / pathology. Vasculitis / pathology
  • [MeSH-minor] Adult. Anti-Inflammatory Agents / therapeutic use. Biopsy. Cyclophosphamide / therapeutic use. Drug Therapy, Combination. Female. Humans. Immunosuppressive Agents / therapeutic use. Lung / pathology. Prednisone / therapeutic use. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Lung Diseases.
  • MedlinePlus Health Information. consumer health - Vasculitis.
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12693170.001).
  • [ISSN] 2067-2993
  • [Journal-full-title] Pneumologia (Bucharest, Romania)
  • [ISO-abbreviation] Pneumologia
  • [Language] rum
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Romania
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents; 0 / Immunosuppressive Agents; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone
  •  go-up   go-down


20. Hu YH, Hsiao LT, Yang CF, Chiou TJ, Liu JH, Gau JP, Yen CC, Chou TY, Hsu WH, Chen PM, Tzeng CH: Prognostic factors of Chinese patients with primary pulmonary non-Hodgkin's lymphoma: the single-institute experience in Taiwan. Ann Hematol; 2009 Sep;88(9):839-46
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic factors of Chinese patients with primary pulmonary non-Hodgkin's lymphoma: the single-institute experience in Taiwan.
  • Primary pulmonary lymphoma (PPL) accounts for less than 1% of patients with non-Hodgkin's lymphoma, with no report in Chinese patients.
  • Patients with biopsy-proven pulmonary lymphoma were reviewed and re-classified by a hema-pathologist.
  • The histological subtypes included marginal zone B-cell lymphoma of mucosa-associated lymphoid tissues (MALT) in 12 patients (54%), diffuse large B-cell lymphoma in nine (41%), and one case of lymphomatoid granulomatosis.
  • Diseases mainly manifested as pulmonary nodules or masses in 73% of patients, with a higher rate of hilar/mediastinal lymphadenopathy in non-MALT patients (8% vs. 80%, P = 0.002).
  • Eighteen patients (82%) received chemotherapy.
  • The 5-year rates of overall survival (OS) were 91% and 21% for MALT and non-MALT types of PPL, respectively.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19139892.001).
  • [ISSN] 1432-0584
  • [Journal-full-title] Annals of hematology
  • [ISO-abbreviation] Ann. Hematol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


21. Poonawalla T, Colome-Grimmer MI, Kelly B: Ulcerative sarcoidosis in the legs with granulomatous vasculitis. Clin Exp Dermatol; 2008 May;33(3):282-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We present a case of a patient with pulmonary sarcoidosis who developed ulcerative sarcoidosis with granulomatous vasculitis on the lower legs.
  • Granulomatous vasculitis, classically associated with Wegener's granulomatosis, lymphomatoid granulomatosis, or Churg-Strauss syndrome, is also commonly described in pulmonary sarcoidosis.
  • Our patient's leg ulcers have responded well to immunosuppressive therapy with tapered corticosteroid and low-dose azathioprine.
  • [MeSH-minor] Diabetes Mellitus, Type 1 / drug therapy. Diabetes Mellitus, Type 1 / pathology. Diabetic Angiopathies / drug therapy. Diabetic Angiopathies / pathology. Female. Humans. Immunosuppressive Agents / therapeutic use. Leg. Middle Aged. Sarcoidosis, Pulmonary / drug therapy. Sarcoidosis, Pulmonary / pathology. Treatment Outcome


22. Wei CH, Huang YH, Shih YC, Tseng FW, Yang CH: Sarcoidosis with cutaneous granulomatous vasculitis. Australas J Dermatol; 2010 Aug;51(3):198-201
Hazardous Substances Data Bank. PREDNISOLONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Granulomatous vasculitis is classically associated with Wegener's granulomatosis, lymphomatoid granulomatosis or Churg-Strauss syndrome.
  • It is also commonly noted in pulmonary sarcoidosis, but has seldom been reported in cutaneous sarcoidosis, particularly the ulcerative variant.
  • [MeSH-minor] Adult. Azathioprine / therapeutic use. Humans. Male. Prednisolone / therapeutic use. Testicular Diseases / diagnosis. Testicular Diseases / drug therapy. Testicular Diseases / pathology


23. Panchal R, Avery R, Mehta AC, Castillo JR, Farver C, Aboussouan LS: A young man with a cough, an abnormal chest radiograph, and multiple skin lesions. Cleve Clin J Med; 2006 Mar;73(3):273-80
Hazardous Substances Data Bank. Itraconazole .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Antifungal Agents / therapeutic use. Blastomycosis / diagnosis. Blastomycosis / drug therapy. Cough / radiography. Face. Itraconazole / therapeutic use. Lung / radiography
  • [MeSH-minor] Adult. Biopsy. Diagnosis, Differential. Histoplasmosis / diagnosis. Humans. Lymphomatoid Granulomatosis / diagnosis. Male. Practice Guidelines as Topic. Sarcoidosis / diagnosis. Sporotrichosis / diagnosis

  • MedlinePlus Health Information. consumer health - Cough.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16548450.001).
  • [ISSN] 0891-1150
  • [Journal-full-title] Cleveland Clinic journal of medicine
  • [ISO-abbreviation] Cleve Clin J Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antifungal Agents; 304NUG5GF4 / Itraconazole
  •  go-up   go-down






Advertisement